Literature DB >> 27302873

Exploring the latent trait of opioid use disorder criteria among frequent nonmedical prescription opioid users.

João Mauricio Castaldelli-Maia1, Laura H Andrade2, Katherine M Keyes3, Magdalena Cerdá4, Daniel J Pilowsky5, Silvia S Martins6.   

Abstract

BACKGROUND: There is a need to explore the dimensional and categorical phenotypes of criteria of opioid use disorder among frequent nonmedical users of prescription opioids (NMUPO) users.
METHODS: We used pooled data of 2011-2012 National Survey on Drug Use and Health to examine reliability and phenotypic variability in the diagnosis of OUD secondary to NMUPO in a nationally-representative sample of 18+ years-old frequent past-year NMUPO users (120+ days, n = 806). Through exploratory factor analysis (EFA) and latent class analysis (LCA), we examined 10 past-year OUD criteria. We examined associations between the latent classes and sociodemographic/psychiatric/NMUPO correlates.
RESULTS: OUD criteria were unidimensional, and a three-class model was the overall best fitting solution for characterizing individuals into phenotypes along this unidimensional continuum: a "non-symptomatic class" (40.7%), "Tolerance-Time spent class" (29.0%) with high probability of endorsing Tolerance/Time Spent criteria, and a "High-moderate symptomatic class" (30.1%). The last class was significantly associated with being male, having insurance and obtaining prescription opioids (PO) nonmedically via "doctor shopping" as compared to the non-symptomatic class. "Tolerance-Time spent class" was significantly associated with being younger (18-25 years) and obtaining PO nonmedically from family/friends as compared to the non-symptomatic class.
CONCLUSION: This study revealed the different characteristics and routes of access to PO of different classes of frequent NMUPO users. It is possible that these groups may respond to different interventions, however such conclusions would require a clinical study.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Doctor shopping; NMUPO; Prescription opioids; Time spent; Tolerance

Mesh:

Substances:

Year:  2016        PMID: 27302873      PMCID: PMC4980160          DOI: 10.1016/j.jpsychires.2016.05.007

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  48 in total

1.  Characteristics of a nontreatment-seeking sample of over-the-counter codeine users: implications for intervention and prevention.

Authors:  Suzanne Nielsen; Jacqui Cameron; Nicole Lee
Journal:  J Opioid Manag       Date:  2011 Sep-Oct

2.  Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002.

Authors:  Carlos Blanco; Donald Alderson; Elizabeth Ogburn; Bridget F Grant; Edward V Nunes; Mark L Hatzenbuehler; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2007-05-21       Impact factor: 4.492

3.  Use transition between illegal drugs among Brazilian university students.

Authors:  João Mauricio Castaldelli-Maia; Silvia S Martins; Lúcio Garcia de Oliveira; Margriet van Laar; Arthur Guerra de Andrade; Sergio Nicastri
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-08-06       Impact factor: 4.328

4.  Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology.

Authors:  C F Turner; L Ku; S M Rogers; L D Lindberg; J H Pleck; F L Sonenstein
Journal:  Science       Date:  1998-05-08       Impact factor: 47.728

5.  Latent class analysis of DSM-5 criteria for opioid use disorders: results from the Iranian National Survey on Mental Health.

Authors:  Mohammad Javad Tarrahi; Afarin Rahimi-Movaghar; Hojjat Zeraati; Seyed Abbas Motevalian; Masoumeh Amin-Esmaeili; Ahmad Hajebi; Vandad Sharifi; Reza Radgoodarzi; Mitra Hefazi; Akbar Fotouhi
Journal:  Eur Addict Res       Date:  2015-02-11       Impact factor: 3.015

6.  Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria.

Authors:  Joseph A Boscarino; Margaret R Rukstalis; Stuart N Hoffman; John J Han; Porat M Erlich; Stephen Ross; Glenn S Gerhard; Walter F Stewart
Journal:  J Addict Dis       Date:  2011 Jul-Sep

7.  Pain and motives for use among non-treatment seeking individuals with prescription opioid dependence.

Authors:  Kelly S Barth; Megan Moran-Santa Maria; Katie Lawson; Stephanie Shaftman; Kathleen T Brady; Sudie E Back
Journal:  Am J Addict       Date:  2013-05-15

8.  Dimensionality of lifetime alcohol abuse, dependence and binge drinking.

Authors:  Deborah S Hasin; Cheryl L Beseler
Journal:  Drug Alcohol Depend       Date:  2008-12-17       Impact factor: 4.492

9.  Assessment of doctor-shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database.

Authors:  Vincent Pradel; Xavier Thirion; Eléonore Ronfle; Alain Masut; Joëlle Micallef; Bernard Bégaud
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-07       Impact factor: 2.890

10.  The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence.

Authors:  Saul Shiffman; Andrew Waters; Mary Hickcox
Journal:  Nicotine Tob Res       Date:  2004-04       Impact factor: 4.244

View more
  2 in total

1.  Caution Is Necessary When Estimating Treatment Need for Opioid Use Disorder Using National Surveys.

Authors:  Elizabeth D Nesoff; Silvia S Martins; Joseph J Palamar
Journal:  Am J Public Health       Date:  2022-02       Impact factor: 9.308

2.  An Item Response Theory Analysis of DSM-5 Heroin Use Disorder in a Clinical Sample of Chinese Adolescents.

Authors:  Hongmei Yang; Fu Chen; Xiaoxiao Liu; Tao Xin
Journal:  Front Psychol       Date:  2019-10-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.